Micro-x Ltd. · ASX:MX1
Micro-x — Bell Potter Healthcare Conference 2023
21 slides from Micro-x's conference presentation, Nov 14, 2023
Slide 1: Bell Potter Healthcare Conference 2023 announcement
Micro-X Limited, ABN 21 153 273 735 BELL POTTER HEALTHCARE CONFERENCE 2023 15 November 2023, 1.30pm (AEDT) Adelaide, Australia, 14th November 2023: Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company), a leader in cold cathode x-ray technology for health and security markets glo
Slide 2: Investor Presentation: Relentless pursuit of commercial outcomes
For personal use only I N V E S T O R P R E S E N TAT I O N Relentless pursuit of commercial outcomes Bell Potter Healthcare Conference 14 – 16 November 2023 Bell Potter Healthcare Conference I 1
Slide 3: Important Notice
I M P O RTA N T N OT I C E For personal use only S C O P E & L I M I T A T I O N S This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not contain all the information about the Company’s assets and liabilities, financ
Slide 4: Creating revolutionary imaging to better lives
For personal use only C R E AT I N G R E V O L U T I O N A R Y I M A G I N G TO BETTER LIVES Commercialisation I Te c h n o l o g y I People Bell Potter Healthcare Conference I 3
Slide 5: The future of x-ray: smaller, lighter, reliable
T H E F U T U R E O F X - R AY Smaller, lighter, reliable For personal use only Lighter Micro-X Proprietary CNT technology - carbon nanotube emitter made of No heat millions of nanotubes emitting digitally controlled electrons - generate high quality x-ray images Fast pulse Smaller Nano Electronic X
Slide 6: Four innovative products
F O U R I N N O VAT I V E P R O D U C T S Each product drives a different utilisation of Micro-X’s world leading technology For personal use only Mobile Digital Radiology Argus X-ray Camera Checkpoints & Baggage Scanner Brain CT Lightweight and ultra-mobile x-ray World first high-definition bomb ima
Slide 7: Our strategy
O U R S T R AT E G Y Creating a profitable business with our world class technology For personal use only 01 02 03 Commercial skills Sweat the asset Target larger and - Commercially driven - Leverage our technology less competitive markets Building commercial skills - prioritising commercial Created
Slide 8: Reduced & aligned cost base
REDUCED & ALIGNED COST BASE Reduction in unfunded activities and building new commercial partnerships For personal use only Total Cost Base Unfunded Cost Base Improving the mix of Funded development * Reducing the unfunded cost base* $20m $18.7m $17.9m 4.3m 9.6m $15m $5.4m $5.9m FY22: FY23: FY24: $1
Slide 9: 2024 – Recent progress
2024 – RECENT PROGRESS New leadership delivering on strategic objectives For personal use only $2.9m sales Q1 [FY23 $3.8m] Argus pipeline $21m DHS contract ext. More focused approach to customers and Multiple customer engagements and US Dept of Homeland Security for Airport delivery into new segment
Slide 10: Product portfolio
For personal use only PRODUCT PORTFOLIO L e v e r a g i n g p r o p r i e t a r y N E X Te c h n o l o g y
Slide 11: Mobile DR
MOBILE DR First product to market validating revolutionary technology For personal use only Distinct product advantages and range of uses → Smaller, more mobile, full range of imaging applications → Meets hospital mobile imaging requirements and military needs → Applications in elite sports and vete
Slide 12: Argus X-ray Camera
A R G U S X - R AY C A M E R A Saving lives by redefining bomb detection For personal use only Unique product advantages and range → Stand-off detection of potential bomb threats or IEDs – removes operator from threat → One sided imaging enables imaging of otherwise inaccessible targets → Only robot
Slide 13: Checkpoints
CHECKPOINTS Next generation self-service security screening For personal use only Significant advantages for travellers + airports → Faster – Passenger screening in 30 seconds, 8 passengers screened simultaneously. → Safer – Passenger, baggage, and Identification combined with AI to increase detecti
Slide 14: Brain CT
BRAIN CT Taking stroke diagnosis from the hospital to the ambulance For personal use only Saving lives with stroke diagnosis in any ambulance → Mobile – 70kg unit suitable for all road and air ambulances → Accurate – 8 second scan for 3D imaging down to 2ml blood → Enabler – Life saving response tim
Slide 15: Driving commercial success
For personal use only DRIVING COMMERCIAL SUCCESS B u i l d i n g a b u s i n e s s n o t j u s t a t e c h n o l o g y
Slide 16: Revenue timeline
REVENUE TIMELINE Commercialising four revenue generating product lines by 2026 For personal use only Revenue Timeline Division Sector Products Commercial Status 2023 2024 2025 2026 Next major milestone $3.8m Revenue – FY23 CE Mark Mobile DR Healthcare FDA and TGA Sales in Europe Sales in Europe 350+
Slide 17: Partners for growth
PA R T N E R S F O R G R O W T H De-risking development and unlocking value from our Technology For personal use only Development Partner Development Partner Licensing Partner Leading technology Checkpoints - $28m funding Brain CT - $8m funding Multibeam Emitters - $15m Transform the passenger secur
Slide 18: Experienced leadership
EXPERIENCED LEADERSHIP Commercially focused to accelerate growth For personal use only Ilona Meyer, Non Exec Patrick O'Brien , Non Exec General Counsel Nuix, former Boehringer Former Director Macquarie Group, Ingelheim, Resmed, Medtronic McKinsey and Minter Ellison Kingsley Hall – Chief Executive Da
Slide 19: Corporate & financials
C O R P O R AT E For personal use only & FINANCIALS FINANCIALS & SHAREHOLDERS SHARE CAPITAL (1 November 2023) ~A$1.3m (30 September 2023) Cash Share price $0.14 per share Committed cash inflows + $7.2m received October 2023 - $7.2m cash received in October Revenue A$15.0m (FY2023) +67% Total shares
Slide 20: Summary
S U M M A RY Pioneers in carbon nanotube x-ray technology For personal use only Creating revolutionary imaging to better lives → Pioneers in proprietary carbon nanotube X-ray technology – Nano Electronic X-ray (NEX) → Innovative product portfolio spanning healthcare and security applications Platfor
Slide 21: Thank you
For personal use only ACN 153 273 735 / ASX: MX1 THANK YOU Bell Potter Healthcare Conference I 20